Resveratrol analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol

被引：0
|
作者：
Zengshuan Ma
Ommoleila Molavi
Azita Haddadi
Raymond Lai
Robert A. Gossage
Afsaneh Lavasanifar
机构：
[1] University of Alberta,Faculty of Pharmacy and Pharmaceutical Sciences, 4119 Dentistry
[2] Cross Cancer Institute and University of Alberta,Pharmacy Building
[3] Acadia University,Department of Laboratory Medicine and Pathology
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 63卷
关键词：
DMU-212; Resveratrol; Apoptosis; Cell cycle; Tubulin; Stat3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：27 / 35
页数：8
相关论文
共 50 条
  • [21] (Z)3,4,5,4′-trans-tetramethoxystilbene, a new analogue of resveratrol, inhibits gefitinb-resistant non-small cell lung cancer via selectively elevating intracellular calcium level
    Fan, Xing-Xing
    Yao, Xiao-Jun
    Xu, Su Wei
    Wong, Vincent Kam-Wai
    He, Jian-Xing
    Ding, Jian
    Xue, Wei-Wei
    Mujtaba, Tahira
    Michelangeli, Francesco
    Huang, Min
    Huang, Jun
    Xiao, Da-Kai
    Jiang, Ze-Bo
    Zhou, Yan-Ling
    Kam, Richard Kin-Ting
    Liu, Liang
    Leung, Elaine Lai-Han
    SCIENTIFIC REPORTS, 2015, 5
  • [22] The resveratrol analogue 4,4′-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol
    Savio, M.
    Coppa, T.
    Bianchi, L.
    Vannini, V.
    Maga, G.
    Forti, L.
    Cazzalini, O.
    Lazze, M. C.
    Perucca, P.
    Prosperi, E.
    Stivala, L. A.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (12): : 2493 - 2502
  • [23] Anti-mitotic properties of resveratrol analog (Z)-3,5,4′-trimethoxystilbene
    Chabert, Philippe
    Fougerousse, Andre
    Brouillard, Raymond
    BIOFACTORS, 2006, 27 (1-4) : 37 - 46
  • [24] Anti-tumor effects and mechanism of 4′-bromo-resveratrol in a BRAFV600F/PTENNULL melanoma mouse model
    Chhabra, G.
    Singh, C. K.
    Ndiaye, M. A.
    Ahmad, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S93 - S93
  • [25] A resveratrol analog termed 3,3,4,4,5,5-hexahydroxy-trans-stilbene is a potent HIV-1 inhibitor
    Han, Ying-Shan
    Quashie, Peter K.
    Mesplede, Thibault
    Xu, Hongtao
    Quan, Yudong
    Jaeger, Walter
    Szekeres, Thomas
    Wainberg, Mark A.
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (12) : 2054 - 2060
  • [26] 3,5,2'4'-Tetramethoxystilbene, a fully methylated resveratrol analog, prevents platelet aggregation and thrombus formation by targeting the protease-activated receptor 4 pathway
    Chiang, Yi-Chun
    Wu, Yu-Shan
    Kang, Ya-Fei
    Wang, Hui-Chun
    Tsai, Meng-Chun
    Wu, Chin-Chung
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 357
  • [27] Vasorelaxant effect of 3,5,4′-trihydroxy-trans-stilbene (resveratrol) and its underlying mechanism
    Chu Shan Tan
    Yeah Chun Loh
    Wan Yin Tew
    Mun Fei Yam
    Inflammopharmacology, 2020, 28 : 869 - 875
  • [28] Vasorelaxant effect of 3,5,4′-trihydroxy-trans-stilbene (resveratrol) and its underlying mechanism
    Tan, Chu Shan
    Loh, Yeah Chun
    Tew, Wan Yin
    Yam, Mun Fei
    INFLAMMOPHARMACOLOGY, 2020, 28 (04) : 869 - 875
  • [29] The resveratrol analogue 3,5,3′,4′,5′- pentahydroxy-trans-stilbene inhibits cell transformation via MEK
    Lee, Ki Won
    Kang, Nam Jon
    Rogozin, Evgeny A.
    Oh, Sang-Muk
    Heo, Yong Seok
    Pugliese, Angelo
    Bode, Ann M.
    Lee, Hvong Joo
    Dong, Zigang
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (11) : 2487 - 2496
  • [30] Resveratrol analog (Z)-3,5,4′-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization
    Schneider, Y
    Chabert, P
    Stutzmann, J
    Coelho, D
    Fougerousse, A
    Gossé, F
    Launay, JF
    Brouillard, R
    Raul, F
    INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (02) : 189 - 196
12345